last data update: 2011/10/14, 20:38

Website loading time

during the test: 0.44 s

cable connection (average): 0.59 s

DSL connection (average): 0.73 s

modem (average): 8.4 s

HTTP headers

Information about DNS servers

fiercepharma.comA74.205.46.249IN21027
fiercepharma.comNSns0.dnsmadeeasy.comIN42627
fiercepharma.comNSns2.dnsmadeeasy.comIN42627
fiercepharma.comNSns3.dnsmadeeasy.comIN42627
fiercepharma.comNSns4.dnsmadeeasy.comIN42627
fiercepharma.comNSns1.dnsmadeeasy.comIN42627

Received from the first DNS server

Request to the server "fiercepharma.com"
You used the following DNS server:
DNS Name: ns0.dnsmadeeasy.com
DNS Server Address: 208.94.148.2#53
DNS server aliases:

HEADER opcode: REQUEST, status: NOERROR, id: 34970
flag: qr aa rd REQUEST: 1, ANSWER: 14, AUTHORITY: 0, ADDITIONAL: 2

REQUEST SECTION:
fiercepharma.com. IN ANY

ANSWER SECTION:
fiercepharma.com. 86400 IN NS ns3.dnsmadeeasy.com.
fiercepharma.com. 86400 IN NS ns4.dnsmadeeasy.com.
fiercepharma.com. 86400 IN NS ns2.dnsmadeeasy.com.
fiercepharma.com. 86400 IN NS ns1.dnsmadeeasy.com.
fiercepharma.com. 86400 IN NS ns0.dnsmadeeasy.com.
fiercepharma.com. 21600 IN A 74.205.46.249
fiercepharma.com. 21600 IN MX 10 aspmx5.googlemail.com.
fiercepharma.com. 21600 IN MX 1 aspmx.l.google.com.
fiercepharma.com. 21600 IN MX 5 alt1.aspmx.l.google.com.
fiercepharma.com. 21600 IN MX 5 alt2.aspmx.l.google.com.
fiercepharma.com. 21600 IN MX 10 mail.fiercepharma.com.
fiercepharma.com. 21600 IN MX 10 aspmx2.googlemail.com.
fiercepharma.com. 86400 IN TXT "v=spf1 ip4:208.95.132.73 ip4:208.66.206.23 mx a:fiercemarkets.com -all"
fiercepharma.com. 86400 IN SOA ns0.dnsmadeeasy.com. dns.dnsmadeeasy.com. 2006010137 43200 3600 1209600 180

SECTION NOTES:
mail.fiercepharma.com. 21600 IN A 74.205.124.101
mail.fiercepharma.com. 21600 IN A 72.3.226.221

Received 458 bytes from address 208.94.148.2#53 in 14 ms

Received from the second DNS server

Request to the server "fiercepharma.com"
You used the following DNS server:
DNS Name: ns2.dnsmadeeasy.com
DNS Server Address: 208.80.126.2#53
DNS server aliases:

HEADER opcode: REQUEST, status: NOERROR, id: 48470
flag: qr aa rd REQUEST: 1, ANSWER: 14, AUTHORITY: 0, ADDITIONAL: 2

REQUEST SECTION:
fiercepharma.com. IN ANY

ANSWER SECTION:
fiercepharma.com. 86400 IN NS ns3.dnsmadeeasy.com.
fiercepharma.com. 86400 IN NS ns4.dnsmadeeasy.com.
fiercepharma.com. 86400 IN NS ns2.dnsmadeeasy.com.
fiercepharma.com. 86400 IN NS ns1.dnsmadeeasy.com.
fiercepharma.com. 86400 IN NS ns0.dnsmadeeasy.com.
fiercepharma.com. 21600 IN A 74.205.46.249
fiercepharma.com. 21600 IN MX 10 aspmx2.googlemail.com.
fiercepharma.com. 21600 IN MX 10 aspmx5.googlemail.com.
fiercepharma.com. 21600 IN MX 1 aspmx.l.google.com.
fiercepharma.com. 21600 IN MX 5 alt1.aspmx.l.google.com.
fiercepharma.com. 21600 IN MX 5 alt2.aspmx.l.google.com.
fiercepharma.com. 21600 IN MX 10 mail.fiercepharma.com.
fiercepharma.com. 86400 IN TXT "v=spf1 ip4:208.95.132.73 ip4:208.66.206.23 mx a:fiercemarkets.com -all"
fiercepharma.com. 86400 IN SOA ns0.dnsmadeeasy.com. dns.dnsmadeeasy.com. 2006010137 43200 3600 1209600 180

SECTION NOTES:
mail.fiercepharma.com. 21600 IN A 72.3.226.221
mail.fiercepharma.com. 21600 IN A 74.205.124.101

Received 458 bytes from address 208.80.126.2#53 in 13 ms

Subdomains (the first 50)

Typos (misspells)

diercepharma.com
ciercepharma.com
viercepharma.com
giercepharma.com
tiercepharma.com
riercepharma.com
fuercepharma.com
fjercepharma.com
fkercepharma.com
foercepharma.com
f9ercepharma.com
f8ercepharma.com
fiwrcepharma.com
fisrcepharma.com
fidrcepharma.com
firrcepharma.com
fi4rcepharma.com
fi3rcepharma.com
fieecepharma.com
fiedcepharma.com
fiefcepharma.com
fietcepharma.com
fie5cepharma.com
fie4cepharma.com
fierxepharma.com
fiervepharma.com
fierfepharma.com
fierdepharma.com
fiercwpharma.com
fiercspharma.com
fiercdpharma.com
fiercrpharma.com
fierc4pharma.com
fierc3pharma.com
fierceoharma.com
fiercelharma.com
fierce-harma.com
fierce0harma.com
fiercepgarma.com
fiercepbarma.com
fiercepnarma.com
fiercepjarma.com
fiercepuarma.com
fiercepyarma.com
fiercephzrma.com
fiercephsrma.com
fiercephwrma.com
fiercephqrma.com
fiercephaema.com
fiercephadma.com
fiercephafma.com
fiercephatma.com
fiercepha5ma.com
fiercepha4ma.com
fiercepharna.com
fiercepharka.com
fiercepharja.com
fiercepharmz.com
fiercepharms.com
fiercepharmw.com
fiercepharmq.com
iercepharma.com
fercepharma.com
fircepharma.com
fiecepharma.com
fierepharma.com
fiercpharma.com
fierceharma.com
fierceparma.com
fiercephrma.com
fiercephama.com
fiercephara.com
fiercepharm.com
ifercepharma.com
feircepharma.com
firecepharma.com
fiecrepharma.com
fierecpharma.com
fiercpeharma.com
fiercehparma.com
fiercepahrma.com
fiercephrama.com
fiercephamra.com
fiercepharam.com
ffiercepharma.com
fiiercepharma.com
fieercepharma.com
fierrcepharma.com
fierccepharma.com
fierceepharma.com
fierceppharma.com
fiercephharma.com
fiercephaarma.com
fiercepharrma.com
fiercepharmma.com
fiercepharmaa.com

Location

IP: 74.205.46.249

continent: NA, country: United States (USA), city: Washington

Website value

rank in the traffic statistics:

There is not enough data to estimate website value.

Basic information

website build using CSS

code weight: 55.75 KB

text per all code ratio: 10 %

title: Pharma News, Pharma Industry, Pharmaceuticals Industry --- Fierce Pharma

description: Visit FiercePharma for pharma industry news on big pharma, FDA decisions, patents, pharmaceutical marketing, generic drugs, and other pharma news.

keywords: Pharmaceutical News, Pharma News, Pharma Industry, Pharmaceutical Industry News, Pharma, Pharma Company, Pharmaceutical Company, FDA regulation, FDA news, Big Pharma, Pharmaceutical Marketing, Pharmaceutical Contract Manufacturing, Pharmaceutical Industry

encoding: utf-8

language: en

Website code analysis

one word phrases repeated minimum three times

PhraseQuantity
Clinical4
Research4
Job3
Events3
Drug3
Celgene3
Corporation3
US3
NJ,3
Development3
Jobs3
Pharma3
>>3

two word phrases repeated minimum three times

PhraseQuantity
Job Celgene3
Celgene Corporation3
NJ, US3

three word phrases repeated minimum three times

PhraseQuantity
Job Celgene Corporation3

B tags

U tags

I tags

images

file namealternative text
FierceBiotech
FierceBiotech IT
FiercePharma
FierceMedicalDevices
FierceBiotech Research
FierceVaccines
FiercePharma Manufacturing
FierceDrugDelivery
Syndicate content
Clicky

headers

H1

Latest News

H2

Free Newsletter

Hottest Products

Featured Jobs

Popular Topics

Events

Latest News

Also Noted

Press Releases

Popular Comment Threads

Special Report

News

Whitepapers

Paid Research Reports

H3

Free Newsletter

Hottest Products

Featured Jobs

Popular Topics

Events

Latest News

Also Noted

Press Releases

Popular Comment Threads

Special Report

News

Whitepapers

Paid Research Reports

H4

H5

H6

internal links

addressanchor text
Help
Home
News
About
View Sample
Privacy
Pfizer
GlaxoSmithKline
Merck
FDA
Eli Lilly
AstraZeneca
Novartis
drug safety
Roche
FDA approval
Johnson & Johnson
Sanofi-Aventis
Amgen
pharmaceutical layoffs
More tags...
About
View Sample
Privacy
Top 10 Biopharma CEO salaries of 2010
NICE on BMS's Yervoy: The cost is too darn high
Report
Syndicate content
Spain's Faes looks for new revenue sources
Teva wraps Cephalon buy, agrees to sell Provigil copy
OB/GYN group says KV's Makena deserves reimbursement
Will NHS use of Avastin spark a price cut for Lucentis?
NICE on BMS's Yervoy: The cost is too darn high
Faltering Incivek growth might be an IMS data quirk
Private equity looks for $905M in sale of Japan's Showa
Kohl backs drug-spending cuts focused on Medicare Part B
Ipsen weighs strategies for Russian growth
Weak cancer meds, Tamiflu take bite out of Roche sales
More news
Story
$TEVA
$BAX
Read more >>
New Data on Teva’s Copaxone® and Laquinimod to Be Highlighted at ECTRIMS/ACTRIMS
Teva Completes Acquisition of Cephalon
K-V PHARMACEUTICAL COMMENTS ON ACOG AND SMFM INFORMATION UPDATE REGARDING 17-ALPHA HYDROXYPROGESTERONE CAPROATE - FDA-APPROVED M
NICE consults on a new treatment for skin cancer
Boston Scientific Welcomes Introduction of Medical Device Regulatory Improvement Act in U.S. Senate
Teva Completes Acquisition of Cephalon
More Press Releases >>
Submit a press release
Home
Subscribe
RSS
Privacy
Site Map
Editors
FiercePharma

external links

addressanchor text
Advertise
Contact
Features
Events
eBooks
Whitepapers
Webinars
Research
Jobs
Marketplace
Clinical Trial Management Software (CTMS)
Pharmaceutical Drug Development
Clinical Research Organizations (CRO)
Monoclonal Antibodies
Polyclonal Antibodies
Drug Safety Information
Evaluate more than 400,000 products >>
Director, Clinical Research Physician - Early Development II Job
Partner
Associate Director Global Market Research Job
Director, Clinical Development
Manager, Government Pricing (U.S. Pricing Compliance) Job
More Jobs >>
Master's Degree in Molecular Biotechnology
YourEncore Bio-Pharma Networking Event
Pharma/Bio Congress on Oncology Drug Development
Next Generation Sequencing Generates Momentum
More Events >>
@FiercePharma
News
Story
Item
5 device/diagnostic companies to watch
Report>>
Top 10 Standout CMOs
See report
Top 10 medical device venture capital deals, H1 2011
Report>>
Pharma Manufacturing News
Pain patch maker warned by FDA over validation reporting
China assesses illegal drug activities
Genzyme's Ireland site expanded
Teva walloped $163M in hepC ruling, doc 'unfit' for trial
Ex-Genzyme ops chief joins board at bio start-up
More >>
Biotech News
Epizyme scores $4M in ongoing GSK alliance
Biotechs lug big risks with option-based pharma deals
Capstone Therapeutics axing 78% of jobs in 'hibernation' move
Forest Labs eyes 'earlier' assets for drug pipeline, next decade of business
Medivation chief amps up rhetoric on Ph3 prostate cancer drug
More >>
Biotech Research News
Chocolate – the miracle drug?
United Therapeutics wins $45M deal for oral antiviral
Natural compound shows promise as a pathway to diabetes pill
Diabetes science team finds a "negative regulator" for insulin secretion
Cloning tech used to create breakthrough stem cells for research
More >>
Vaccines News
Michael J. Fox Foundation bankrolls AFFiRiS Parkinson's vaccine
CA law lets tweens make HPV vaccination decisions
Inovio, VGX ink hep B and C vaccine deal
HepB vax Heplisav posts positive Ph3 data
Coridon HSV-2 vaccine shows 100% efficacy
More >>
WHITE PAPER: Four Strategies for Cost-Effective Pharmacovigilance
Let travelers smell your rich media content
Forum Signature File : solution for Media Marketing
Best Practices: ERP Vendor Reference-Checking
BRAND-NEW COMPOUNDS
The Adverse Impact of the US Reimbursement System on the Development and Adoption of Personalized Medicine Diagnostics
More Whitepapers >>
Trends in mHealth and Telemedicine
The Global Aesthetic Dermatology Market Outlook
Future Directions in Regenerative Medicine
Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
More Research Reports >>
Mobile Edition
List in Marketplace
Supplier in Marketplace
FierceEnergy
FierceSmartGrid
FierceFinance
FierceFinanceIT
FierceComplianceIT
FierceHealthFinance
FierceHealthIT
Hospital Impact
FierceMobileHealthcare
FierceHealthPayer
FiercePracticeManagement
FierceEMR
FierceCIO
FierceContentManagement
FierceMobileIT
FierceGovernmentIT
FierceGovernment
FierceHomelandSecurity
FierceBiotech Research
FierceVaccines
FierceBiotechIT
FiercePharma Manufacturing
FierceMedicalDevices
FierceDrugDelivery
FierceIPTV
FierceTelecom
FierceEnterpriseCommunications
FierceBroadbandWireless
FierceDeveloper
FierceWireless
FierceWireless:Europe
FierceCable